OREANDA-NEWS. Lonza today announced that it has published its Annual Report 2014 and its invitation to the Annual General Meeting 2015, which will take place on Wednesday, 8 April 2015, at 10:00 a.m. CET, at the Congress Center Messe Basel, Messeplatz 21, 4058 Basel, Switzerland.

The Board of Directors is proposing re-election of all members of the Board of Directors, as well as the re-election of the Chairperson Rolf Soiron to ensure leadership continuity in Lonza’s transformational phase.

Following the revision last year of Lonza’s Articles of Association in accordance with the Swiss Ordinance Against Excessive Compensation by Public Corporations, the Annual General Meeting will include a new, binding approval of the maximum compensation of the Board of Directors, in addition to three approvals of the (maximum) aggregate amount of fixed, variable short-term and variable long-term compensation of the Executive Committee.

Details on the other motions can be found in the invitation to the Annual General Meeting.

About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Lonza’s stock is publicly traded on the Swiss and the Singapore stock exchanges.